Johnson & Johnson plans to launch in late September what may be the largest clinical trial to date against a coronavirus vaccine, enrolling up to 60,000 people worldwide to test whether the experimental shot safely protects against Covid-19. The targeted enrollment, reported on a government database and confirmed by the …
Read More »
(Photo by Joe Raedle / Getty Images) Getty Images Text size Here’s what you need to know about the impact of Covid-19 to navigate the markets today. • President Donald Trump said Friday that McKesson would work with the U.S. government to spread a coronavirus vaccine if one is approved. …
Read More »
The stock market may fall if a COVID-19 vaccine receives formal FDA approval. I know I’m advancing myself because it does not guarantee that an effective vaccine will ever be produced. But with eight faxes now in Phase III studies, and with Russia claiming bragging rights by being the first …
Read More »
The UK government said on Friday it had signed deals for a further 90 million doses of coronavirus vaccines as the country raced to secure supplies of experimental shots to combat the pandemic. Under the new agreements in principle, the American medicine developer Novavax NVAX, + 7.12% will supply 60 …
Read More »
Text size Andrey Rudakov / Bloomberg Novavax said it has a deal with SK Bioscience to produce the antigen component of its Covid-19 vaccine candidate during the pandemic period. The stock jumped more than 9% Thursday morning. Novavax (ticker: NVAX) said its development and supply agreement with the South Korean …
Read More »